Ignite Creation Date:
2025-12-24 @ 4:19 PM
Ignite Modification Date:
2025-12-27 @ 12:24 AM
Study NCT ID:
NCT05563766
Status:
RECRUITING
Last Update Posted:
2025-11-05
First Post:
2022-09-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
Sponsor:
VA Office of Research and Development
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2029-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-06-15
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-27
First Submit QC Date:
None
Study First Post Date:
2022-10-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-03
Last Update Post Date:
2025-11-05
Last Update Post Date Type:
ESTIMATED